Back in May, I presented at career day for the third-graders. I was warned by my then third-grader that I couldn’t come unless I shared “cool stuff” as opposed to the boring stuff he thinks I do most of the time. So, I approached my cooler colleagues and gathered case histories and collateral for work we do for a shoe/sporting good manufacturer, a fast food restaurant, a camera company — the cooler stuff. The third-graders asked great questions but the most interesting discussions were centered around how much celebrities charged to help on the campaigns and that the kids thought it was okay for the celebrities to get paid “because everyone knows that they don’t do it for free.”
For many reasons, I’m delighted to learn that the big pharmaceutical companies like Merck and Eli Lilly are now going to disclose payments to physicians, CME grants etc. (www.pharmalot.com), but one clear reason for my appreciation of this long overdue news is that “we all know doctors get paid.” Pretending they didn’t created unnecessary skepticism for an industry that does far more good than harm. I never quite understood why it was a secret in the past.
I know that there was the worry that reputation would be damaged because the public or other stakeholders would not understand the nature of the payments but let’s face it, keeping that information under wraps didn’t exactly protect their reputations and by the way, why was there anything to hide? Fees paid to physicians for their insight, counsel, expertise are fair and appropriate. Lending their credibility and expertise to the sharing of information through publication or medical education is really no different than a celebrity lending their cool factor to a product they use and believe in.
To assume a spokesperson fee or the costs associated with a clinical trial results in bad medicine is a blanket indictment that is neither fair nor logical. Most people don’t lend their names and reputation to something they don’t believe in. Most doctors didn’t attend medical school with the hope of becoming a spokesperson…they did it because they wanted to practice good medicine, create breakthroughs for hard to treat diseases or improve quality of life for chronically ill patients. Sure, there are some bad apples, as in any industry, who let dollars influence behavior to the detriment of patients — but not most — not even close. But these are not new insights. It’s the factual message that pharma has tried to relay for years — to deaf ears.
So, why am I so delighted that they have publicly announced disclosure plans? Because now, we can move on to what really matters — finding a way for this industry to continue to provide breakthrough science to manage disease for as many people as possible. Some would argue that the fees paid to doctors are more about marketing than fighting disease — could be. But, without that physician/industry engagement, the breakthroughs are impossible to achieve. And, I for one, will be happy to know that the company innovating a new solution has engaged expert physicians to vet the studies, study the product in clinical practice and educate their peers on appropriate use.
